Literature DB >> 11777527

ACOG Committee opinion. Number 266, January 2002 : placenta accreta.

.   

Abstract

The incidence of placenta accreta has increased 10-fold in the past 50 years and now occurs with a frequency of 1 per 2,500 deliveries. Women who have had two or more cesarean deliveries with anterior or central placenta previa have nearly a 40% risk of developing placenta accreta. If the diagnosis or strong suspicion of placenta accreta is formed before delivery, the patient should be counseled about the likelihood of hysterectomy and blood transfusion. Blood products and clotting factors should be available. Cell saver technology should be considered if available as well as the appropriate location and timing for delivery to allow access to adequate surgical personnel and equipment. A preoperative anesthesia assessment should be obtained.

Entities:  

Mesh:

Year:  2002        PMID: 11777527     DOI: 10.1016/s0029-7844(01)01748-3

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  16 in total

1.  [Placenta praevia totalis et increta. Cause of life-threatening haemorrhaging during a caesarean section].

Authors:  U Grundmann; A K Ertan; S Jacob; S Kreuer
Journal:  Anaesthesist       Date:  2007-08       Impact factor: 1.041

2.  Morbidly adherent placenta: a critical review.

Authors:  Richa Aggarwal; Amita Suneja; Neelam Bala Vaid; Ponam Yadav; Abha Sharma; Kiran Mishra
Journal:  J Obstet Gynaecol India       Date:  2012-04-20

Review 3.  Magnetic resonance imaging of the placenta and gravid uterus: a pictorial essay.

Authors:  Daniel C Oppenheimer; Parisa Mazaheri; David H Ballard; Motoyo Yano; Kathryn J Fowler
Journal:  Abdom Radiol (NY)       Date:  2019-02

4.  The sonographic appearance and obstetric management of placenta accreta.

Authors:  Charleen Sze-Yan Cheung; Ben Chong-Pun Chan
Journal:  Int J Womens Health       Date:  2012-11-26

Review 5.  Invasive placentation and uterus preserving treatment modalities: a systematic review.

Authors:  Charlotte N Steins Bisschop; Timme P Schaap; Tatjana E Vogelvang; Piet C Scholten
Journal:  Arch Gynecol Obstet       Date:  2011-06-03       Impact factor: 2.344

6.  Preservation of fertility and subsequent childbirth after methotrexate treatment of placenta percreta: a case report.

Authors:  Masato Tamate; Motoki Matsuura; Shutaro Habata; Yushi Akashi; Ryoichi Tanaka; Shinichi Ishioka; Toshiaki Endo; Tsuyoshi Saito
Journal:  J Med Case Rep       Date:  2015-10-19

Review 7.  Contemporary issues in the management of abnormal placentation during pregnancy in developing nations: An Indian perspective.

Authors:  Sukhwinder Kaur Bajwa; Anita Singh; Sukhminder Jit Singh Bajwa
Journal:  Int J Crit Illn Inj Sci       Date:  2013-07

8.  A comparison of cell-free placental messenger ribonucleic acid and color Doppler ultrasound for the prediction of placental invasion in patients with placenta accreta.

Authors:  Elham Naghshineh; Elahe Khorvash; Sara Kamali
Journal:  Adv Biomed Res       Date:  2015-01-30

9.  The value of ultrasound and magnetic resonance imaging in diagnostics and prediction of morbidity in cases of placenta previa with abnormal placentation.

Authors:  Ahmed M Algebally; Reda Ramadan Hussein Yousef; Sanaa Sayed Hussein Badr; Amal Al Obeidly; Wojciech Szmigielski; Abdullah A Al Ibrahim
Journal:  Pol J Radiol       Date:  2014-11-12

10.  Efficacy of Intrauterine Bakri Balloon Tamponade in Cesarean Section for Placenta Previa Patients.

Authors:  Hee Young Cho; Yong Won Park; Young Han Kim; Inkyung Jung; Ja-Young Kwon
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.